Danuglipron: Pfizer moves forward with once-daily weight-loss pill
- 11-Jul-2024
Pfizer has selected a preferred once-daily modified-release formulation for its weight loss candidate danuglipron, as the company looks to get ahead in the oral weight loss market. The company reached the preferred choice after an analysis of its ongoing Phase II pharmacokinetic study. Whilst several candidates showed encouraging data, one showed “the most favourable profile”, […]